Login / Signup
Durable Responses with ALK Inhibitors for Primary Refractory Anaplastic Lymphoma Kinase-Positive Large B Cell Lymphoma.
Radhika Takiar
Tycel Jovelle Phillips
Published in:
Blood advances (2023)
Keyphrases
</>
diffuse large b cell lymphoma
advanced non small cell lung cancer
tyrosine kinase
protein kinase